Selective Glucocorticoid Receptor modulators

Papadimitriou, 2009, Regulation of the hypothalamic–pituitary–adrenal axis, Neuroimmunomodulation, 16, 265, 10.1159/000216184 Schäcke, 2002, Mechanisms involved in the side effects of glucocorticoids, Pharmacol. Ther., 96, 23, 10.1016/S0163-7258(02)00297-8 Schäcke, 2006, Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index, Exp. Dermatol., 15, 565, 10.1111/j.1600-0625.2006.00453.x Miesfeld, 1984, Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells, Nature, 312, 779, 10.1038/312779a0 Hollenberg, 1985, Primary structure and expression of a functional human glucocorticoid receptor cDNA, Nature, 318, 635, 10.1038/318635a0 Kumar, 2005, Gene regulation by the glucocorticoid receptor: structure:function relationship, J. Steroid Biochem. Mol. Biol., 94, 383, 10.1016/j.jsbmb.2004.12.046 Beck, 2009, Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases, Endocr. Rev., 30, 830, 10.1210/er.2009-0013 Rosenfeld, 2006, Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response, Genes Dev., 20, 1405, 10.1101/gad.1424806 Bledsoe, 2002, Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition, Cell, 110, 93, 10.1016/S0092-8674(02)00817-6 Madan, 1993, Bidirectional transport of glucocorticoid receptors across the nuclear envelope, Proc. Natl. Acad. Sci. U.S.A., 90, 3588, 10.1073/pnas.90.8.3588 Pratt, 2003, Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery, Exp. Biol. Med. (Maywood), 228, 111, 10.1177/153537020322800201 Wang, 2007, Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase, Mol. Endocrinol., 21, 625, 10.1210/me.2005-0338 Deroo, 2002, Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors, J. Steroid Biochem. Mol. Biol., 81, 309, 10.1016/S0960-0760(02)00072-9 Adams, 2003, Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants, Mol. Endocrinol., 17, 2583, 10.1210/me.2002-0305 Reddy, 2009, Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation, Genome Res., 19, 2163, 10.1101/gr.097022.109 George, 2009, Dynamic access of the glucocorticoid receptor to response elements in chromatin, Int. J. Biochem. Cell Biol., 41, 214, 10.1016/j.biocel.2008.09.019 John, 2009, Kinetic complexity of the global response to glucocorticoid receptor action, Endocrinology, 150, 1766, 10.1210/en.2008-0863 Kino, 2004, Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function, Mol. Med., 10, 80, 10.2119/2005-00026.Kino Meijsing, 2007, The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release, Mol. Cell. Biol., 27, 2442, 10.1128/MCB.01570-06 Meijsing, 2009, DNA binding site sequence directs glucocorticoid receptor structure and activity, Science, 324, 407, 10.1126/science.1164265 Liberman, 2007, Glucocorticoids in the regulation of transcription factors that control cytokine synthesis, Cytokine Growth Factor Rev., 18, 45, 10.1016/j.cytogfr.2007.01.005 Liberman, 2009, Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells, FASEB J., 23, 1558, 10.1096/fj.08-121236 Liberman, 2007, The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein–protein interaction, FASEB J., 21, 1177, 10.1096/fj.06-7452com Ogawa, 2005, Molecular determinants of crosstalk between nuclear receptors and toll-like receptors, Cell, 122, 707, 10.1016/j.cell.2005.06.029 Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6 Tuckermann, 1999, The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin, J. Cell Biol., 147, 1365, 10.1083/jcb.147.7.1365 Reichardt, 2001, Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor, EMBO J., 20, 7168, 10.1093/emboj/20.24.7168 Rogatsky, 2003, Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor, Proc. Natl. Acad. Sci. U.S.A., 100, 13845, 10.1073/pnas.2336092100 Bilodeau, 2006, Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease, Genes Dev., 20, 2871, 10.1101/gad.1444606 Rosenfeld, 2001, Coregulator codes of transcriptional regulation by nuclear receptors, J. Biol. Chem., 276, 36865, 10.1074/jbc.R100041200 Groner, 2000, Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors, Growth Horm. IGF Res., 10, S15, 10.1016/S1096-6374(00)80004-0 Kabotyanski, 2009, Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements, J. Biol. Chem., 284, 22815, 10.1074/jbc.M109.032490 Vayssiere, 1997, Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo, Mol. Endocrinol., 11, 1245, 10.1210/mend.11.9.9979 Glyn, 1998, The discovery and early use of cortisone, J. R. Soc. Med., 91, 513, 10.1177/014107689809101004 Belvisi, 2001, Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity, J. Immunol., 166, 1975, 10.4049/jimmunol.166.3.1975 Janka-Junttila, 2006, The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophils, J. Inflamm. (Lond.), 3, 1, 10.1186/1476-9255-3-10 Eberhardt, 2005, Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cells, Biochem. Pharmacol., 70, 433, 10.1016/j.bcp.2005.05.007 Tanigawa, 2002, In vivo analysis of glucocorticoid-induced reporter gene expression using gene gun DNA delivery, Biol. Pharm. Bull., 25, 1115, 10.1248/bpb.25.1115 Chivers, 2006, Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids, Mol. Pharmacol., 70, 2084, 10.1124/mol.106.025841 Humphrey, 2006, Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells, Bone, 38, 652, 10.1016/j.bone.2005.10.004 Shah, 2004, Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands, Bioorg. Med. Chem. Lett., 14, 5199, 10.1016/j.bmcl.2004.07.052 Coghlan, 2003, A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects, Mol. Endocrinol., 17, 860, 10.1210/me.2002-0355 Renaud, 1995, Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid, Nature, 378, 681, 10.1038/378681a0 Bourguet, 2000, Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains, Mol. Cell, 5, 289, 10.1016/S1097-2765(00)80424-4 Herzig, 2001, CREB regulates hepatic gluconeogenesis through the coactivator PGC-1, Nature, 413, 179, 10.1038/35093131 Yoon, 2001, Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1, Nature, 413, 131, 10.1038/35093050 Rogatsky, 2001, Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones, EMBO J., 20, 6071, 10.1093/emboj/20.21.6071 Owen, 2007, The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438, Mol. Cell. Endocrinol., 264, 164, 10.1016/j.mce.2006.11.006 Schacke, 2004, Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects, Proc. Natl. Acad. Sci. U.S.A., 101, 227, 10.1073/pnas.0300372101 López, 2008, LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo, Endocrinology, 149, 2080, 10.1210/en.2007-1353 Swart, 2003, Biological activities of the shrub Salsola tuberculatiformis Botsch.: contraceptive or stress alleviator?, Bioessays, 25, 612, 10.1002/bies.10285 De Bosscher, 2005, A fully dissociated compound of plant origin for inflammatory gene repression, Proc. Natl. Acad. Sci. U.S.A., 102, 15827, 10.1073/pnas.0505554102 Dewint, 2008, A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis, J. Immunol., 180, 2608, 10.4049/jimmunol.180.4.2608 Robertson, 2010, Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound A, J. Biol. Chem., 285, 8061, 10.1074/jbc.M109.087866 Gossye, 2009, Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts, Arthritis Rheum., 60, 3241, 10.1002/art.24963 Zhang, 2009, Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects, J. Immunol., 183, 3081, 10.4049/jimmunol.0901088 van Loo, 2010, Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis, Mol. Endocrinol., 24, 310, 10.1210/me.2009-0236 Wust, 2009, Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis, PLoS One, 4, e8202, 10.1371/journal.pone.0008202 Gossye, 2010, A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance, Ann. Rheum. Dis., 69, 291, 10.1136/ard.2008.102871 Schäcke, 2007, Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index, Mol. Cell. Endocrinol., 275, 109, 10.1016/j.mce.2007.05.014 Kuzmich, 2007, Identification of dissociated non-steroidal glucocorticoid receptor agonists, Bioorg. Med. Chem. Lett., 17, 5025, 10.1016/j.bmcl.2007.07.031 Biggadike, 2007, Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity, J. Med. Chem., 50, 6519, 10.1021/jm070778w Clackers, 2007, Non-steroidal glucocorticoid agonists: the discovery of aryl pyrazoles as A-ring mimetics, Bioorg. Med. Chem. Lett., 17, 4737, 10.1016/j.bmcl.2007.06.066 Thompson, 2007, Novel glucocorticoids containing a 6,5-bicyclic core fused to a pyrazole ring: synthesis, in vitro profile, molecular modeling studies, and in vivo experiments, Bioorg. Med. Chem. Lett., 17, 3354, 10.1016/j.bmcl.2007.03.103 Robinson, 2009, Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration, J. Med. Chem., 52, 1731, 10.1021/jm801512v Wang, 2006, Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity, Genes Dev., 20, 689, 10.1101/gad.1400506 Yemelyanov, 2008, Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells, Cancer Res., 68, 4763, 10.1158/0008-5472.CAN-07-6104 Hudson, 2007, Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma, J. Med. Chem., 50, 4699, 10.1021/jm070370z Duma, 2006, Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification, J. Steroid Biochem. Mol. Biol., 102, 11, 10.1016/j.jsbmb.2006.09.009 Lu, 2007, Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor, Mol. Cell. Biol., 27, 7143, 10.1128/MCB.00253-07 D.J. Roohk, K.A. Varady, S.M. Turner, C.L. Emson, R.W. Gelling, M. Shankaran, G. Lindwall, L.E. Shipp, T.S. Scanlan, J.C. Wang, M.K. Hellerstein, Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared to prednisolone, J. Pharmacol. Exp. Ther., in press. Nader, 2009, Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications, FASEB J., 23, 1572, 10.1096/fj.08-117697 Stahn, 2007, Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists, Mol. Cell. Endocrinol., 275, 71, 10.1016/j.mce.2007.05.019 Vreugdenhil, 2009, MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain, Endocrinology, 150, 2220, 10.1210/en.2008-1335 Chou, 2006, Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies, Pharmacol. Rev., 58, 621, 10.1124/pr.58.3.10 Zimmermann, 2009, Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug, Arthritis Res. Ther., 11, R12, 10.1186/ar2602 Lehar, 2009, Synergistic drug combinations tend to improve therapeutically relevant selectivity, Nat. Biotechnol., 27, 659, 10.1038/nbt.1549 Bougarne, 2009, PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB, Proc. Natl. Acad. Sci. U.S.A., 106, 7397, 10.1073/pnas.0806742106 Bougarne, 2009, Circumventing glucocorticoid-mediated hyperinsulinemia via the activation of PPARalpha, Cell Cycle, 8, 2311, 10.4161/cc.8.15.9220 Beck, 2009, Glucocorticoids and mitogen- and stress-activated protein kinase 1 inhibitors: possible partners in the combat against inflammation, Biochem. Pharmacol., 77, 1194, 10.1016/j.bcp.2008.12.008 Van Cleemput, 2009, Hop bitter acids efficiently block inflammation independent of GRalpha, PPARalpha, or PPARgamma, Mol. Nutr. Food Res., 53, 1143, 10.1002/mnfr.200800493 Biggadike, 2009, Design and X-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor, Proc. Natl. Acad. Sci. U.S.A., 106, 18114, 10.1073/pnas.0909125106 Vanden Berghe, 1999, Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism, Mol. Pharmacol., 56, 797 Schacke, 2009, Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases, Br. J. Pharmacol., 158, 1088, 10.1111/j.1476-5381.2009.00238.x Thompson, 2005, Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy, Bioorg. Med. Chem. Lett., 15, 2163, 10.1016/j.bmcl.2005.02.009 Regan, 2006, Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists, J. Med. Chem., 49, 7887, 10.1021/jm061273t